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Background: Ultraviolet-inactivated, replication-defective Sendai virus particles (Z strain) have displayed antitumor
effect through enhancing the immune responses or inducing apoptosis in a variety of carcinomas. Sendai virus
strain Tianjin was isolated from the lungs of marmoset and proved to be a novel genotype of Sendai virus. In this
study, we explored the antitumor effect and its mechanism of ultraviolet-inactivated, replication-defective Sendai
virus strain Tianjin (UV-Tianjin) in mice bearing CT26 colon carcinoma.
Methods: Three injections of UV-Tianjin were delivered into CT26 tumors growing on the back of BALB/c mice.
Tumor size was measured in a blinded manner and survival rate of mice was calculated. In order to make clear
antitumor mechanism of UV-Tianjin, the maturation and interleukin-6 (IL-6) release from murine myeloid dendritic
cells (DCs) was examined by flow cytometry or ELISA assay after induced by UV-Tianjin and compared with those of
live virus. Moreover, real-time RT-PCR and immunohistochemistry was performed to identify whether UV-Tianjin
could induce infiltration of DCs, CD4+ and CD8+ T cells into tumors. The TUNEL assay was done to observe the
apoptosis of CT26 tumor cells after UV-Tianjin injection.
Results: In animal model, UV-Tianjin could obviously inhibit the growth of CT26 tumors and prolong the survival of
the tumor-bearing mice compared with control group (P < 0.01). In vitro murine DCs stimulated by UV-Tianjin
underwent dose-dependent maturation, similar to that elicited by live virus. And the secretion amount of IL-6 from
DCs induced by UV-Tianjin was a little lower than that released in the presence of live virus. Real-time RT-PCR and
immunohistochemistry revealed that UV-Tianjin induced a remarkable infiltration of DCs, CD4+ and CD8+ T cells
into tumors. The TUNEL assay showed that the apoptosis index of tumor tissues injected with UV-Tianjin was
significantly higher than that of control group (P < 0.01).
Conclusions: Our results have demonstrated that UV-Tianjin alone could inhibit the growth of CT26 tumor in mice
through enhancing host antitumor immunity and inducing apoptosis of tumor cells. Therefore, UV-Tianjin shows its
prospect as a novel drug for carcinoma therapy.
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Table 1 Sequences of primers used in the real-time PCR
amplifications
Gene Primer sequence PCR product
CD4 F:5’-TTGTGCATGTCACACATGAA-3’ 550 bp
R:5’-CCTGTGTTCCATGTAGTGGC-3’
CD8 F:5’-GTCCGTTTCGCAAGGATGCT-3’ 543 bp
R:5’-CCTTCCTGTCTGACTAGCGG-3’
CD11c F:5’-GAAAGTGTGAAGTTGCTTCT-3’ 500 bp
R:5’-ACATGTCTGCTGCTACAGCT-3’
GAPDH F:5’-AGGCCGGTGCTGAGTATGTC-3’ 530 bp
R:5’-TGCCTGCTTCACCACCTTCT-3’
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Cancer has been one of the most serious diseases threat-
ening to human health. Although the mortality of cancer
patients has improved by operation, chemotherapy and
radiotherapy, some advanced or metastatic tumors re-
main refractory to conventional treatment. Therefore,
novel therapeutic approaches are urgently required to
treat refractory tumors.
It is known for several decades that some viruses may
be able to eradicate tumors. For example, adenovirus
vector containing P53 gene has passed through clinical
trials in many countries and proved to have therapeutic
effects on various tumors [1,2]. Moreover, a variety of
live viruses such as mumps virus, measles virus, Newcas-
tle disease virus (NDV), reovirus and vesicular stomatitis
virus (VSV) have been used for cancer treatment due to
their ability of killing tumor cells selectively [3-7]. Sendai
virus (SeV; also known as hemagglutinating virus of
Japan, HVJ) is a member of the genus Respirovirus
within the family Paramyxoviridae. It usually causes out-
breaks of lethal pneumonia in mouse colonies, the natural
host, but is thought to be nonpathogenic to humans. UV-
inactivated Sendai virus (called HVJ-envelope, HVJ-E) is
unable to replicate in cells because the genome is
destroyed by UV irradiation, but conserves the complete
structure of the live HVJ envelope containing F, HN, and
M proteins [8]. Therefore, HVJ-E is safe and has been ap-
plied to an anticancer vaccine strategy [9,10]. Recent stud-
ies have demonstrated that HVJ-E (Z strain) has an
extensive antitumor role and could eradicate or inhibit the
growth of various tumors, including colon carcinoma,
renal carcinoma, prostate cancer, malignant glioma, and
melanoma through inducing antitumor immunity or
tumor cell apoptosis [11-15]. However, the detailed mech-
anism of the antitumor activity of HVJ-E is not fully
understood.
Sendai virus strain Tianjin (GenBank: EF679198.1) was
isolated from the lungs of marmoset with respiratory in-
fection in 1999. Phylogenetic analysis based on complete
sequence has proved that Tianjin strain was a novel
genotype of Sendai virus [16]. Our previous study has
shown that non-replicating Tianjin strain could enhance
the immune response through inducing the production
of IFN-α, IL-6 and TNF-α in vivo [17]. This study was
designed to demonstrate that UV-inactivated Tianjin
strain alone may suppress colon carcinoma growing in
mice through inducing not only immune response but
also tumor cell apoptosis, which may be useful in devel-
oping viral therapeutics for cancer.
Materials and methods
Cell lines and mice
The CT26 murine colon carcinoma cell line was pur-
chased from Cell Bank of Chinese Academy of Science(Shanghai, China). The cell line was maintained in RPMI
1640 supplemented with 10% FCS (Hyclone, Beijing,
China), 100 U/ml penicillin and 100 U/ml streptomycin
under a humidified atmosphere containing 5% CO2 at
37°C. Six-week-old, female BALB/c mice purchased from
Beijing HFK Bioscience Co., Ltd. (Beijing, China), were
maintained in a temperature-controlled and pathogen-
free room. All animals were handled according to the
approved protocols and the guidelines of the Animal
Committee of Tianjin Medical University.Reagents and antibodies
Recombinant mouse IL-4 and GM-CSF were purchased
from PeproTech Inc. (Suzhou, China). PE anti-mouse
CD11c, FITC anti-mouse CD40, CD80, CD86 antibodies,
PE Armenian Hamster IgG Isotype Ctrl, FITC Rat
IgG2α, κ Isotype Ctrl, FITC Armenian Hamster IgG
Isotype Ctrl were purchased from BioLegend (Beijing,
China). Mouse IL-6 ELISA kit was obtained from
RayBiotech (Guangzhou, China). Anti-CD11c antibody
was purchased from Abcam Ltd (Hong Kong, China).
Anti-CD4 antibody was purchased from R&D Systems
China Co. Ltd. (Shanghai, China). Anti-CD8α antibody
was from Santa Cruz Biotechnology Inc. (Beijing, China).
TUNEL apoptosis assay kit was purchased from Roche
Applied Science (Hong Kong, China).Preparation of live Tianjin strain and UV-inactivated
Tianjin strain
Tianjin strain (GenBank: EF679198.1) was preserved in
our laboratory and propagated in the chorioallantoic
fluid of 10-day-old embryonated chicken eggs, after
which it was purified by centrifugation and inactivated
by UV irradiation (99 mJ/cm2), as previously described
[8]. Inactivated virus is unable to replicate because the
genome is destroyed by UV irradiation, but its capacity
for viral fusion remains intact.
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Dendritic cells (DCs) were generated from the bone
marrow precursors of BALB/c mice as described in ref-
erence [18]. In brief, bone marrow of the tibia and femur
was flushed with culture medium and treated with RBC
lysis buffer for 5 min, washed twice with PBS, then cul-
tured in complete RPMI 1640 medium supplemented
with 20 ng/ml recombinant mouse GM-CSF and 20 ng/
ml recombinant mouse IL-4. Half of the medium was re-
placed at day 2 and 4. At day 6, the suspended and
loosely adherent cells were collected and CD11c mol-
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Figure 1 Tumor growth inhibition by intratumor injection of UV-Tian
on the back of BALB/c mice. Particles of UV-Tianjin (5 × 108 each) or saline we
saline-treated BALB/c mice 3 weeks after tumor inoculation. The tumors treate
growth of UV-Tianjin-treated tumors was strongly suppressed compared with
mean ± SD of the relative tumor volume Vt/V0 (where Vt denotes the tumor v
volume at the beginning of treatment). *P < 0.01 vs. control group. Arrows ind
colon carcinoma following three consecutive injections of UV-Tianjin or saline
day 60 by UV-Tianjin. *P < 0.01 vs. control group. D, Microscopic view of CT26
infection). a, Live Tianjin strain infection produced an obvious cytopathic effec
monolayer. b, UV-Tianjin infection can’t produce visible CPE. c, Healthy contro
representative of three independent experiments.These cells were used in subsequent experiments as im-
mature dendritic cells.Flow cytometric analysis
Immature murine DCs (1 × 106 cells/ml) were placed in
6‐well plates and cultured with different doses of UV-
inactivated Tianjin strain or live virus for 48 h. Then the
DCs were incubated with anti‐mouse CD40, CD80, and
CD86 antibodies, respectively. The stained cells were
then analyzed with the BD FACSCalibur system and
CellQuest software (BD Biosciences).Saline
Tianjin Control
b c























jin. A to C, 5 × 106 CT26 cells were inoculated into subcutaneous space
re injected into tumors on days 4, 8, and 12. A, UV-Tianjin-treated or
d by UV-Tianjin were much smaller than those treated by saline. B, The
saline-treated tumors. Each point in the curve was expressed as the
olume at test time point and V0 denotes the corresponding initial tumor
icate the timing of injection. C, Survival curve of the mice bearing CT26
, revealed a significant increasing of survival rate from 30% to 100% at
cells infected with live Tianjin strain or UV-Tianjin on 4 dpi (days post
t (CPE) characterized by cell rounding and detachment from the
l. Photographs are shown at 100× magnification. Results are
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Immature murine DCs (1 × 106 cells/ml) were cultured
in 96‐well plates and then different doses of UV-
inactivated Tianjin strain or live virus were added to the
culture medium. After 48 h, supernatants of DCs cul-
tures were harvested. Murine IL‐6 in harvested superna-
tants was measured using ELISA kits according to the
manufacturer’s instruction. Supplied standards were
used to generate standard curves.
In vivo antitumor effect
CT-26 cells were enzymatically detached from culture
flasks and counted. 5 × 106 CT26 cells were resuspended
in 100 μl PBS and injected into the subcutaneous space
on the back of BALB/c mice (day 0). When tumors
reached 5 mm in diameter, the mice were randomly di-
vided into two groups (n = 10 per group). One group
served as control and received one intratumoral admin-
istration of 100 μl saline. The other group was
intratumorally administered with UV-Tianjin, once at a
dose of 5 × 108 in 100 μl saline on days 4, 8 and 12.
Tumor size was measured in a blinded manner with
slide calipers every other day, and survival of the animals
was monitored. Tumor volume was calculated by using
the following formula: tumor volume (mm3) = length ×









Figure 2 Culture and identification of dendritic cells. A, Morphological
DCs (×400). b, Infected with UV-Tianjin (MOI = 200) for 48 h (×400). Black arrow
cytometric analysis of the expressing of CD11c molecule specific for DCs cultu
experiments.Quantitative real-time RT-PCR
Tumors were removed at 24, 48, and 120 h after three
injections of UV-Tianjin or saline. Total RNA was
extracted using an RNeasy Mini Kit (Qiagen, Shenzhen,
China). A total of 1 μg of RNA was reverse transcribed
into cDNA with cDNA Reverse Transcription Kit (TaKaRa
Bio, Dalian, China) and amplified by IQ SYBR Green
Supermix (BioRad, Beijing, China) using a BioRad IQ5
icycler detection system under the following conditions:
initial denaturation at 94°C for 3 min followed by 40 cycles
of denaturation at 94°C for 30 s, annealing at 55°C for 30 s,
and elongation at 72°C for 1 min. All procedures were car-
ried out according to the manufacturer’s instructions. The
2-ΔΔCT equation was used to analyze the data. The data
were presented as the fold change in gene expression
normalized to an endogenous reference gene GAPDH
(glyceraldehyde-3- phosphate dehydrogenase) and relative
to the untreated control. ΔΔCT= (CT, Target–CT,
GAPDH) treated sample–(CT, Target–CT, GAPDH) un-
treated control. Primer pairs specific for murine CD4, CD8,
CD11c, and GAPDH were synthesized by TaKaRa Bio
(Dalian, China) and their sequences are listed in Table 1.
Immunohistochemical analysis of tumor tissue
Tumor tissues were harvested at 48 h after UV-Tianjin
or saline injections for three successive days. All tumornfected with UV-Tianjin for 48 h (×400)
b
observation of dendritic cells cultured in vitro for 8 days. a, Non-infected
s indicate mature DCs with many dendritic protrusions. B, Flow
red in vitro for 6 days. Results are representative of three independent
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embedded in paraffin. Thin sections were stained with
specific antibodies in combination with secondary anti-
bodies according to the manufacturer’s instruction. The
presence of brown granules on the surface of cells was
defined as positive cell. The number of positive cells per
section was counted in 10 random high-power micro-
scopic fields (×400), and the percentage of positive cells
(positive cells/total cells × 100%) was calculated [19].
Three discontinuous sections were selected from every
specimen and those indexes were averaged. The final
results were expressed as percentage mean ± standard
deviation (SD).
In situ detection of apoptotic cells in tumor tissue
At 48 h after three successive injections of UV-Tianjin
or saline, tumor tissues were taken out from the mice.
All tumor tissues were fixed in 10% neutral buffered for-
malin and embedded in paraffin. Analysis of apoptotic
cells was performed by TUNEL apoptosis assay kit follow-
ing the manufacturer’s direction. Images of the sections
were taken by a fluorescence microscope (Olympus,A
C




































Figure 3 Activation of murine dendritic cells by UV-Tianjin. A to C, Th
after 48 h of coculture with UV-Tianjin or live virus. Murine dendritic cells were
CD86, showing that UV-Tianjin retained the immunogenicity of live Tianjin stra
at 48 h after coculture with UV-Tianjin or live virus. Amounts of IL-6 were slight
dose of live virus. Columns represent mean value of triplicate samples and barsJapan). Apoptotic index was calculated by dividing the
number of TUNEL-positive cells by the total number of
cells in the field.
Statistical analysis
All data were expressed as means ± SD and analyzed by
one way ANOVA test with Fisher’s adjustment, except
for animal survival. Survival was analyzed with the
Kaplan-Meier method and the log-rank test. A probability
value of P < 0.05 was considered statistically significant.
Results
UV-Tianjin inhibited the growth of CT26 tumors and
prolonged the survival of the treated mice
To determine the antitumor effect of UV-inactivated
Tianjin strain, virus particles of 5 × 108 UV-Tianjin in a
total volume of 100 μl were injected into CT26 tumors
growing on the backs of syngeneic BALB/c mice. As
shown in Figure 1A, B, and C, three consecutive injections
of UV-Tianjin could obviously inhibit the growth of CT26
tumors and significantly prolonged the survival of the
treated mice as compared to control group (P < 0.01). WeB
D

































e expressions of CD40, CD80 and CD86 were measured by flow cytometry
dose-dependently maturated by virus particles to express CD40, CD80 and
in. D, IL-6 secretion was measured in dendritic cell supernatants by ELISA
ly diminished after UV-Tianjin stimulation compared with corresponding
represent SD. Representative of three independent experiments.
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direct contact with UV-Tianjin in vitro (Figure 1D).
UV-Tianjin induced maturation and IL-6 release from
murine dendritic cells
On day 6 of culture, the suspended and loosely adherent
cells derived from murine bone marrow were collected.
Flow cytometric analysis to determine the purity of den-
dritic cells showed that more than 90% of the cells were
positive for CD11c (Figure 2B). Then different doses of
UV-Tianjin or live virus were incubated with these cells
for 48 h and the maturation of DCs was observed under
microscope. More mature DCs were seen in UV-Tianjin
as well as live Tianjin strain group compared with control
group, especially in high dose groups (Figure 2A). In
addition, the expressing of markers of DCs maturation,
CD40, CD80 and CD86 molecules were analyzed by flow
cytometry. They were all dose-dependently increased by
UV-Tianjin or live virus (Figure 3A, 3B and 3C). These re-
sults suggested that UV-Tianjin remained the antigenicity
of live virus. Next, the amount of representative pro-




















































Figure 4 Dendritic cell and T-cell infiltration into tumor in vivo. A, mR
after three successive injections of 5 × 108 UV-Tianjin particles or saline. The ex
tumors were significantly higher than those in corresponding saline-treated tu
Each value was calculated as fold increase relative to value of saline-treated g
SD. B, Electrophoretogram of RT-PCR amplification of CD4, CD8 and CD11c. L
lane 4, CD11c (500 bp); lane 5, GAPDH (530 bp). One representative gel is shomedium was measured by ELISA at 48 h after UV-Tianjin
or live Tianjin strain treatment. The result showed that
the secretion amount of IL-6 by UV-Tianjin was a little
lower than that released in the presence of corresponding
dose of live virus (Figure 3D).
UV-Tianjin promoted dendritic cell and T-cell recruitment
to tumor beds
To determine how host adaptive immune system reacts to
UV-Tianjin in vivo, the mRNA expressions of CD11c as
marker for DCs and of CD4 and CD8 for effector T cells
were measured in tumors at 24, 48, and 120 h after UV-
Tianjin injection in mice. The expression levels of CD11c,
CD4, especially CD8, were significantly increased by UV-
Tianjin at almost all time points compared with corre-
sponding control group (Figure 4). And they remained on
an upward trend until 120 h after treatment, which was a
little different from the previous study that reported the
expression levels of CD4 and CD11c peaked at 48 h in
HVJ-E-treated tumors. In addition, immunohistochemical
staining was done to evaluate DCs and T-cells infiltration

















NA expression quantified by real-time PCR in tumors at 24, 48, and 120 h
pression levels of CD4, CD11c, especially CD8 in UV-Tianjin-treated
mors at almost all time points. The data were normalized by GAPDH.
roup at the same time point. Columns, mean of triplicate samples; bars,
ane 1, 2000 bp DNA ladder; lane 2, CD4 (550 bp); lane 3, CD8 (543 bp);
wn. The data are representative of three independent experiments.
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cells in UV-Tianjin-treated tumors were (19.60±1.49)%,
(24.12±4.84)% and (19.05±2.91)%, respectively, which were
much higher than those of corresponding control group
(Figure 5A, 5B) (P < 0.01). It revealed that CD11c+, CD4+,
and CD8+ cells were remarkably infiltrated into tumor by
UV-Tianjin.
UV-Tianjin induced the apoptosis of CT26 tumors in mice
To confirm the ability of UV-Tianjin to elicit apoptosis
in vivo, in situ TUNEL staining was carried out on tissue
sections of tumors excised at 48 h after UV-Tianjin in-
jection. As shown in Figure 6A, UV-Tianjin-treated
tumor showed significantly more apoptotic cells (with
brown nuclei) compared with control group. The apop-
tosis index of UV-Tianjin-treated group [(27.8 ± 3.7)%]
was much higher than that of saline-treated group [(3.2 ±










































Figure 5 Histologic findings of tumors. A, Representative sections of tum
magnification, ×400). CD4+ (a and d), CD8+ (b and e) or CD11c+ (c and f) c
tissues were isolated at 48 h after UV-Tianjin or saline injection for three su
shown as histogram bars. UV-Tianjin caused a significantly higher percenta
three independent experiments.the increased tumor cell apoptosis was also responsible for
the antitumor effect of UV-Tianjin in vivo.
Discussion
Viral antitumor effect involves in many kinds of modes
including directly killing the tumor cells, inducing tumor
cells apoptosis and stimulating the immune response of
host. Previous studies have shown that UV-inactivated,
replication-defective Sendai virus particles (HVJ-E) could
induce antitumor immunity through both the activation of
CTL and natural killer (NK) cells and the suppression of
regulatory T cells [11,12]. Furthermore, HVJ-E could also
induce cancer-selective apoptosis via the upregulation of
TRAIL and Noxa downstream of the RIG-I/MAVS
pathway [20].
Sendai virus strain Tianjin is a novel genotype of
Sendai virus. In this study, we applied UV-inactivated,







ors from UV-Tianjin-treated mice (a-c) or saline controls (d-f) (original
ells were remarkably infiltrated into tumor tissues by UV-Tianjin. Tumor
ccessive days. B, The percentage of CD4+, CD8+ and CD11c+ cells were

























Figure 6 The induction of apoptosis in vivo was evaluated by TUNEL staining. Tumor tissues were harvested at 48 h after three injections of
UV-Tianjin or saline. A, Representative photographs of the tumor sections (original magnification, ×400). Brown staining indicates TUNEL-positive nuclei
and blue staining counterstained with hematoxylin indicates TUNEL-negative nuclei. a, UV-Tianjin-treated group; b, Saline-treated group. B, Percentage
of TUNEL positive nuclei was calculated. Each bar represents the “apoptotic index”, expressed as mean ± SD. UV-Tianjin caused a significantly higher
percentage of TUNEL-positive apoptotic cells. *P < 0.01 vs. control. The data are representative of three independent experiments.
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UV-Tianjin markedly inhibited the growth of CT26 tu-
mors and significantly prolonged the survival of the
treated mice. UV-Tianjin is unable to replicate in cells be-
cause the genome is destroyed by UV irradiation. More-
over, our results showed that UV-Tianjin was non-toxic to
murine CT26 cancer cell lines (Figure 1D). Therefore, the
mechanism of antitumor activity for UV-Tianjin was prob-
ably not associated with direct UV-Tianjin cytotoxicity.
DCs are potent antigen presenting cells (APCs) that
play a crucial role in regulating the adaptive immune re-
sponse. DCs process and present antigens to activate
both CD4+ and CD8+ T cells. Thus activation of tumor
antigen-specific CD8+ CTL and CD4+ T helper cells
generates antitumor immune response. In addition, ma-
ture DCs can express high levels of costimulatory mole-
cules CD40, CD80 as well as CD86 and secret IL-6 and
other Thl type cytokines which induce Thl cell immunity
[21]. Recently, the application of DCs in immunotherapy
of tumor has become a research focus in the field of ini-
tiative specific immunotherapy of tumor [22,23]. In the
present study, we examined whether UV-Tianjin could
activate DCs and induce tumor-specific immunity. Wefound that murine DCs underwent dose-dependent mat-
uration by UV-Tianjin and the amount of IL-6 released
from DCs was slightly diminished after UV-Tianjin
stimulation as compared to live virus in vitro. Further-
more, DCs and effector T-cell recruitment to tumors
after UV-Tianjin treatment was suggested from the sig-
nificant increase of CD11c, CD4, and CD8 mRNA ex-
pression. Remarkable infiltrations of DCs and CD4+ and
CD8+ T cells into UV-Tianjin-treated tumors were also
confirmed in immunohistochemical studies. At present,
the precise molecular and cellular mechanisms of activa-
tion of DCs by SeV are not well-understood. HVJ-E is
known to induce maturation of dendritic cells in a Toll-
like receptor-independent manner [24]. In addition, a re-
cent report indicated that HVJ-E could induce cytotoxic T
cells against cancers and inhibit regulatory T cells by IL-6
expression in dendritic cells [11]. These facts support the
induction of anticancer immunity in colon carcinoma by
UV-Tianjin treatment.
Apoptosis is ubiquitous in the majority of tumor cells,
and is important in the genesis and progression of tu-
mors. Previous studies have demonstrated that some vi-
ruses typically inhibit tumors by inducing apoptosis of
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performed TUNEL assay to observe whether cell apop-
tosis was responsible for the antitumor effect of UV-
Tianjin in vivo. Results showed that the apoptotic index
of treatment group was significantly higher than that of
control group. As far as we know, the molecular mech-
anism of HVJ-E–induced apoptosis in cancer cells has
not been fully investigated. Recent data suggested that
TNF-related apoptosis-inducing ligand (TRAIL) and
Noxa represented promising target molecules for cancer
cell-selective apoptosis when the retinoic acid–inducible
gene I/mitochondrial antiviral signaling protein (RIG-I/
MAVS) signaling pathway was activated [20]. In view of
the lack of replicative ability and non-toxicity to cultured
CT26 cells of UV-Tianjin, we hypothesized that the pos-
sible mechanism of UV-Tianjin–induced apoptosis
might be that UV-Tianjin RNA fragments are recognized
by RIG-I and then the activation of the RIG-I/MAVS
pathway triggers cancer cell-selective apoptosis. Further
study is required to provide more proof.Conclusions
Taking all these results together we demonstrated that
UV-Tianjin alone had antitumor activity against colon
carcinoma. Mechanistically, not only antitumor immune
response through DCs and T cells but also tumor cell
apoptosis was responsible for this antitumor effect. But
the detailed mechanism requires to be cleared. To our
knowledge, for the first time we reported the growth in-
hibitory effect of UV-Tianjin on colon carcinoma by in-
ducing antitumor immune response and cell apoptosis.
UV-Tianjin may offer important contributions for the
development of a novel drug to prevent and cure human
cancers including colon carcinoma in the future.Competing interests
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